Dr. Wehrli joined OHSU in its department of cell and developmental biology in 2001, and is a primary investigator at the Knight Cancer Institute. He received his doctoral degree in molecular biology from the University of Zurich, and completed postdoctoral fellowships at Columbia University and the University of Pennsylvania. Dr. Wehrli maintains dual citizenship, in the U.S. and Switzerland. The Wehrli lab includes research assistants Veronica Cochrane and Karen Dewey, as well as administrative assistant Misha Naiman. Dr. Wehrli’s research is focused on Wnt signal pathways, a group of transductors made of proteins that enable communications from the outside to the inside of cells.